The Council for the Indian School Certificate Examinations (CISCE) has released the ISC Computer Science (Subject Code - 868) for the Year 2027 evaluation cycle. It is designed specifically to make ...

Abstract: This paper proposes an adaptive recursive discretization aperture-integration surface-integration (ARD AI-SI) method for the rapid analysis of the electrical performance of ...

Buy: Anthropic exposure via its likely IPO/secondary path (e.g., IPO allocation or liquid proxy like AI-safety/compute beneficiaries). Rationale: Anthropic is pushing “slow/pause” policy while still ...

The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...

Earnings call Recursion Pharmaceuticals delivered strong operational progress with a 30% YoY reduction in operating expenses and an extended cash runway into early 2028. Clinical momentum was ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. logos of OpenAI There’s interesting news coming from Sam Altman’s empire, a firm known for ...

If Google’s AI researchers had a sense of humor, they would have called TurboQuant, the new, ultra-efficient AI memory compression algorithm announced Tuesday, “Pied Piper” — or, at least that’s what ...

As Large Language Models (LLMs) expand their context windows to process massive documents and intricate conversations, they encounter a brutal hardware reality known as the "Key-Value (KV) cache ...

Microsoft Excel remains a cornerstone for data analysts, offering a wide array of functions to streamline workflows and enhance data accuracy. In this deep dive, Mo Chen highlights ten essential Excel ...

SALT LAKE CITY, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and ...

I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be Recursion (RXRX). The reason why I want to go over this biotech next is because the company ...